Luiz Zerbini
Luiz Zerbini
Director / Group Leader
Verified email at - Homepage
Cited by
Cited by
Genomic counter-stress changes induced by the relaxation response
JA Dusek, HH Otu, AL Wohlhueter, M Bhasin, LF Zerbini, MG Joseph, ...
PloS one 3 (7), e2576, 2008
GADD45 proteins: central players in tumorigenesis
R E Tamura, J F de Vasconcellos, D Sarkar, T A Libermann, P B Fisher, ...
Current molecular medicine 12 (5), 634-651, 2012
Constitutive activation of nuclear factor κB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer
LF Zerbini, Y Wang, JY Cho, TA Libermann
Cancer Research 63 (9), 2206-2215, 2003
NF-κB-mediated repression of growth arrest-and DNA-damage-inducible proteins 45α and γ is essential for cancer cell survival
LF Zerbini, Y Wang, A Czibere, RG Correa, JY Cho, K Ijiri, W Wei, ...
Proceedings of the National Academy of Sciences 101 (37), 13618-13623, 2004
Targeting transcription factors for cancer gene therapy
TA Libermann, LF Zerbini
Current gene therapy 6 (1), 17-33, 2006
The receptor tyrosine kinase Axl in cancer: biological functions and therapeutic implications
JD Paccez, M Vogelsang, MI Parker, LF Zerbini
International journal of cancer 134 (5), 1024-1033, 2014
Genes coding for enterotoxins and verotoxins in porcine Escherichia coli strains belonging to different O: K: H serotypes: relationship with toxic phenotypes
M Blanco, JE Blanco, EA Gonzalez, A Mora, W Jansen, TA Gomes, ...
Journal of clinical microbiology 35 (11), 2958-2963, 1997
The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target
JD Paccez, GJ Vasques, RG Correa, JF Vasconcellos, K Duncan, X Gu, ...
Oncogene 32 (6), 689-698, 2013
A novel role for GADD45β as a mediator of MMP-13 gene expression during chondrocyte terminal differentiation
K Ijiri, LF Zerbini, H Peng, RG Correa, B Lu, N Walsh, Y Zhao, N Taniguchi, ...
Journal of biological chemistry 280 (46), 38544-38555, 2005
Nucleoside triphosphate diphosphohydrolase-2 (NTPDase2/CD39L1) is the dominant ectonucleotidase expressed by rat astrocytes
MR Wink, E Braganhol, ASK Tamajusuku, G Lenz, LF Zerbini, ...
Neuroscience 138 (2), 421-432, 2006
Responses to the proinflammatory cytokines interleukin‐1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB …
F Grall, X Gu, L Tan, JY Cho, MS Inan, AR Pettit, U Thamrongsak, ...
Arthritis & Rheumatism 48 (5), 1249-1260, 2003
Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells
X Gu, LF Zerbini, HH Otu, M Bhasin, Q Yang, MG Joseph, F Grall, ...
Cancer research 67 (9), 4219-4226, 2007
The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence
I Bruns, A Czibere, JC Fischer, F Roels, RP Cadeddu, S Buest, ...
Leukemia 23 (5), 892-899, 2009
Differential expression of GADD45β in normal and osteoarthritic cartilage: potential role in homeostasis of articular chondrocytes
K Ijiri, LF Zerbini, H Peng, HH Otu, K Tsuchimochi, M Otero, C Dragomir, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2008
Dissecting major signaling pathways throughout the development of prostate cancer
HB da Silva, EP Amaral, EL Nolasco, NC de Victo, R Atique, CC Jank, ...
Prostate cancer 2013 (1), 920612, 2013
The Ets transcription factor ESE‐1 mediates induction of the COX‐2 gene by LPS in monocytes
FT Grall, WC Prall, W Wei, X Gu, JY Cho, BK Choy, LF Zerbini, MS Inan, ...
The FEBS journal 272 (7), 1676-1687, 2005
Computational repositioning and preclinical validation of pentamidine for renal cell cancer
LF Zerbini, MK Bhasin, JF de Vasconcellos, JD Paccez, X Gu, AL Kung, ...
Molecular cancer therapeutics 13 (7), 1929-1941, 2014
A Novel Pathway Involving Melanoma Differentiation Associated Gene-7/Interleukin-24 Mediates Nonsteroidal Anti-inflammatory Drug–Induced Apoptosis and Growth Arrest of Cancer Cells
LF Zerbini, A Czibere, Y Wang, RG Correa, H Otu, M Joseph, Y Takayasu, ...
Cancer Research 66 (24), 11922-11931, 2006
Combinatorial effect of non-steroidal anti-inflammatory drugs and NF-κB inhibitors in ovarian cancer therapy
LF Zerbini, RE Tamura, RG Correa, A Czibere, J Cordeiro, M Bhasin, ...
PLoS One 6 (9), e24285, 2011
The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
FJ Velloso, AFR Bianco, JO Farias, NEC Torres, PYM Ferruzo, V Anschau, ...
OncoTargets and therapy, 5491-5524, 2017
The system can't perform the operation now. Try again later.
Articles 1–20